A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD

Chest

Volumn 146, Issue 4, 2014, Pages 932-940

  Shrikrishna, Dinesh ^a,b   Tanner, Rebecca J ^a   Lee, Jen Y ^b   Natanek, Amanda ^a,b   Lewis, Amy ^b   Murphy, Patrick B ^c   Hart, Nicholas ^c   Moxham, John ^d   Montgomery, Hugh E ^e   Kemp, Paul R ^b   Polkey, Michael I ^a   Hopkinson, Nicholas S ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; DIPEPTIDYL CARBOXYPEPTIDASE; FOSINOPRIL; LACTOSE; MESSENGER RNA; PLACEBO; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ALOPECIA; ANALYTICAL PARAMETERS; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME INHIBITION; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HEADACHE; HERPES ZOSTER; HUMAN; INCREMENTAL SHUTTLE WALK DISTANCE; LUNG FUNCTION; MAGNETIC STIMULATION; MAJOR CLINICAL STUDY; MALE; MAXIMUM VOLUNTARY CONTRACTION; MUSCLE ATROPHY; MUSCLE CHARACTERISTICS AND FUNCTIONS; MUSCLE DISEASE; MUSCLE EXERCISE; MUSCLE WEAKNESS; NAUSEA; OUTCOME ASSESSMENT; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; THIGH; TREATMENT DURATION; TREATMENT RESPONSE; VASTUS LATERALIS MUSCLE; BLOOD PRESSURE; DRUG EFFECTS; ENDURANCE; EXERCISE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; QUADRICEPS FEMORIS MUSCLE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; FOSINOPRIL; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PHYSICAL ENDURANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE;

EID: 84907939131     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2483     Document Type: Article

References (32)

1. Seymour JM, Spruit MA, Hopkinson NS, et al . The prevalence of quadriceps weakness in COPD and the relationship with disease severity . Eur Respir J . 2010; 36 ( 1 ): 81 - 88 .
2. Shrikrishna D, Patel M, Tanner RJ, et al . Quadriceps wasting and physical inactivity in patients with COPD . Eur Respir J . 2012; 40 ( 5 ): 1115 - 1122 .
3. Gosselink R, Troosters T, Decramer M . Peripheral muscle weakness contributes to exercise limitation in COPD . Am J Respir Crit Care Med . 1996; 153 ( 3 ): 976 - 980 .
4. Shrikrishna D, Hopkinson NS . Chronic obstructive pulmonary disease: consequences beyond the lung . Clin Med . 2012; 12 ( 1 ): 71 - 74 .
5. Swallow EB, Reyes D, Hopkinson NS, et al . Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease . Thorax . 2007; 62 ( 2 ): 115 - 120 .
6. Troosters T, Gosselink R, Decramer M . Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: A randomized trial . Am J Med . 2000; 109 ( 3 ): 207 - 212 .
7. Seymour JM, Moore L, Jolley CJ, et al . Outpatient pulmonary rehabilitation following acute exacerbations of COPD . Thorax . 2010; 65 ( 5 ): 423 - 428 .
8. Shrikrishna D, Astin R, Kemp PR, Hopkinson NS . Renin-angiotensin system blockade: A novel therapeutic approach in chronic obstructive pulmonary disease . Clin Sci (Lond) . 2012; 123 ( 8 ): 487 - 498 .
9. Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P . Musclespecific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting . J Clin Invest . 2005; 115 ( 2 ): 451 - 458 .
10. Yoshida T, Semprun-Prieto L, Sukhanov S, Delafontaine P . IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin- 1 expression . Am J Physiol Heart Circ Physiol . 2010; 298 ( 5 ): H1565 - H1570 .
11. Cohn RD, van Erp C, Habashi JP, et al . Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states . Nat Med . 2007; 13 ( 2 ): 204 - 210 .
12. Doucet M, Dubé A, Joanisse DR, et al . Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD . Thorax . 2010; 65 ( 11 ): 963 - 970 .
13. Woods DR, Brull D, Montgomery HE . Endurance and the ACEI/D polymorphism . Sci Prog . 2000; 83 ( pt 4 ): 317 - 336 .
14. Hopkinson NS, Nickol AH, Payne J, et al . Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease . Am J Respir Crit Care Med . 2004; 170 ( 4 ): 395 - 399 .
15. Hopkinson NS, Eleftheriou KI, Payne J, et al . 19/1 9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease . A m J Clin Nutr . 2006; 83 ( 4 ): 912 - 917 .
16. Di Bari M, van de Poll-Franse LV, Onder G, et al; Health, Aging and Body Composition Study . Antihypertensive medications and differences in muscle mass in older persons: The Health, Aging and Body Composition Study . J Am Geriatr Soc . 2004; 52 ( 6 ): 961 - 966 .
17. Onder G, Penninx BW, Balkrishnan R, et al . Relation between use of angiotensin- converting enzyme inhibitors and muscle strength and physical function in older women: An observational study . Lancet . 2002; 359 ( 9310 ): 926 - 930 .
18. Sumukadas D, Witham MD, Struthers AD, McMurdo ME . Effect of perindopril on physical function in elderly people with functional impairment: A randomized controlled trial . CMAJ . 2007; 177 ( 8 ): 867 - 874 .
19. Andreas S, Herrmann-Lingen C, Raupach T, et al . Angiotensin II blockers in obstructive pulmonary disease: A randomised controlled trial . Eur Respir J . 2006; 27 ( 5 ): 972 - 979 .
20. Goodyear LJ . The exercise pill-too good to be true? N Engl J Med . 2008; 359 ( 17 ): 1842 - 1844.
21. Steiner MC, Roubenoff R, Tal-Singer R, Polkey MI . Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: A translational review . Thorax . 2012; 67 ( 12 ): 1102 - 1109 .
22. Swallow EB, Gosker HR, Ward KA, et al . A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans . J Appl Physiol (1985) . 2007; 103 ( 3 ): 739 - 746 .
23. Rabe KF, Hurd S, Anzueto A, et al; Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary . Am J Respir Crit Care Med . 2007; 176 ( 6 ): 532 - 555 .
24. Di Marco F, Guazzi M, Vicenzi M, et al . Eff ect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study . Pulm Pharmacol Ther . 2010; 23 ( 3 ): 159 - 164 .
25. Guo Q, Minami N, Mori N, et al . Eff ects of estradiol, angiotensin-converting enzyme inhibitor and exercise training on exercise capacity and skeletal muscle in old female rats . Clin Exp Hypertens . 2010; 32 ( 2 ): 76 - 83 .
26. Natanek SA, Gosker HR, Slot IG, et al . Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine? Muscle Nerve . 2013; 48 ( 4 ): 488 - 497 .
27. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG . Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: A systematic review . Eur Heart J . 2005; 26 ( 8 ): 778 - 793 .
28. Beedie CJ, Foad AJ . The placebo effect in sports performance: A brief review . Sports Med . 2009; 39 ( 4 ): 313 - 329 .
29. Minami N, Mori N, Nagasaka M, et al . Effect of high-salt diet or chronic captopril treatment on exercise capacity in normotensive rats . Clin Exp Pharmacol Physiol . 2004; 31 ( 4 ): 197 - 201 .
30. Erman A, Winkler J, Chen-Gal B, et al . Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man . J Hypertens . 1991; 9 ( 11 ): 1057 - 1062 .
31. Lorenz JN . Chymase: The other ACE? Am J Physiol Renal Physiol . 2010; 298 ( 1 ): F35 - F36 .
32. Waschki B, Spruit MA, Watz H, et al . Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study . Respir Med . 2012; 106 ( 4 ): 522 - 530 .